U.S. markets open in 8 hours 36 minutes
  • S&P Futures

    3,726.75
    +36.50 (+0.99%)
     
  • Dow Futures

    29,786.00
    +248.00 (+0.84%)
     
  • Nasdaq Futures

    11,415.50
    +129.75 (+1.15%)
     
  • Russell 2000 Futures

    1,735.90
    +21.00 (+1.22%)
     
  • Crude Oil

    83.85
    +0.22 (+0.26%)
     
  • Gold

    1,709.20
    +7.20 (+0.42%)
     
  • Silver

    20.92
    +0.34 (+1.63%)
     
  • EUR/USD

    0.9835
    +0.0008 (+0.08%)
     
  • 10-Yr Bond

    3.6510
    0.0000 (0.00%)
     
  • Vix

    30.10
    -1.52 (-4.81%)
     
  • GBP/USD

    1.1315
    -0.0004 (-0.04%)
     
  • USD/JPY

    144.7840
    +0.1640 (+0.11%)
     
  • BTC-USD

    19,600.24
    +475.93 (+2.49%)
     
  • CMC Crypto 200

    446.04
    +10.69 (+2.46%)
     
  • FTSE 100

    6,908.76
    +14.95 (+0.22%)
     
  • Nikkei 225

    26,980.95
    +765.16 (+2.92%)
     

AMYRIS TO PRESENT AT THE 42nd ANNUAL COWEN HEALTH CARE CONFERENCE

·1 min read

EMERYVILLE, Calif., Feb. 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform today announced that management will participate in a fireside chat at the 42nd Annual Cowen Health Care Conference on Monday, March 7, 2022, at 1:30 pm ET.

A live webcast of the presentation and a replay will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.

About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris technology platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.

Amyris, the Amyris logo and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/amyris-to-present-at-the-42nd-annual-cowen-health-care-conference-301491274.html

SOURCE Amyris, Inc.